NCT00230828View on ClinicalTrials.gov

Patient-reported Outcomes in the Treatment of Schizophrenia

PHASE3CompletedINTERVENTIONAL

Timeline

Start Date

May 31, 2005

Primary Completion Date

January 31, 2006

Conditions

Schizophrenia

Interventions

DRUG

bifeprunox

All Listed Sponsors

lead

Solvay Pharmaceuticals

INDUSTRY

NCT00230828 - Patient-reported Outcomes in the Treatment of Schizophrenia | Biotech Hunter | Biotech Hunter